Quarterly report pursuant to Section 13 or 15(d)

NOTES PAYABLE (Details Narrative)

v3.23.2
NOTES PAYABLE (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Jul. 28, 2020
Nov. 30, 2022
Nov. 30, 2021
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                
Debt Instrument, Unamortized Discount       $ 2,954,390   $ 2,954,390   $ 2,954,390
Interest Expense, Debt       970,000 $ 698,000 1,907,000 $ 1,382,000  
Lenders [Member]                
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                
Debt Instrument, Unamortized Discount       2,954,000   2,954,000    
Insurance Policy [Member]                
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                
Prepaid expenses       $ 167,500   $ 167,500   418,750
Loan Agreement [Member]                
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                
Notes payable   $ 452,250 $ 984,375          
Monthly principal and interest payments   $ 51,387 $ 111,041          
Monthly loan payments term   nine-month period nine-month period          
Annual interest rate   5.40% 3.64%          
Loan Agreement [Member] | K2 HealthVentures LLC [Member]                
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                
Annual interest rate       13.50%   13.50%    
Secured debt       $ 20,715,000   $ 20,715,000    
Debt description The loan matures on August 1, 2024 and the Company is obligated to make interest only payments for the first 24 months and then interest and equal principal payments for the next 24 months commencing on September 1, 2022              
Debt conversion amount           $ 875,000   $ 5,000,000
Debt conversion per share       $ 4.50   $ 4.50   $ 282.00
Adjustments to Additional Paid in Capital, increase in fair value of conversion option               $ 573,000
Warrants to purchase shares of common stock, exercised 2,874         194,444    
Warrant exercisable price per share $ 208.80              
Proceeds from Warrant Exercises $ 472,000              
Proceeds from prepayment and default features 546,000              
Debt issuance cost 1,244,000              
Final payment 1,590,000     $ 1,590,000   $ 1,590,000    
Loan Agreement [Member] | K2 HealthVentures LLC [Member] | Share-Based Payment Arrangement, Tranche One [Member]                
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                
Secured debt $ 20,000,000              
Loan Agreement [Member] | Debt 1 [Member] | K2 HealthVentures LLC [Member]                
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                
Debt conversion amount               2,000,000
Loan Agreement [Member] | Debt 1a [Member] | K2 HealthVentures LLC [Member]                
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                
Debt conversion amount           $ 4,125,000   $ 875,000
Loan Agreement [Member] | Debt 1a [Member] | K2 HealthVentures LLC [Member] | Minimum [Member]                
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                
Debt conversion per share               $ 282.00
Loan Agreement [Member] | Debt 1a [Member] | K2 HealthVentures LLC [Member] | Maximum [Member]                
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                
Debt conversion per share               $ 4.50
Loan Agreement [Member] | Debt 1b [Member] | K2 HealthVentures LLC [Member]                
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                
Debt conversion amount               $ 1,125,000
Loan Agreement [Member] | Debt 1b [Member] | K2 HealthVentures LLC [Member] | Minimum [Member]                
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                
Debt conversion per share               $ 282.00
Loan Agreement [Member] | Debt 1b [Member] | K2 HealthVentures LLC [Member] | Maximum [Member]                
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                
Debt conversion per share               $ 7.875
Loan Agreement [Member] | Debt 2 [Member] | K2 HealthVentures LLC [Member]                
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                
Debt conversion amount               $ 3,000,000
Amended loan agreement [Member] | K2 HealthVentures LLC [Member]                
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                
Debt description The Company entered into an Amendment to the Loan and Security Agreement (the "Amended Loan and Security Agreement") on October 25, 2022. The Amended Loan and Security Agreement defers the commencement of principal repayments by a one-year period from September 1, 2022 to September 1, 2023 and if the Company raises at least $30 million in net proceeds through capital raising transactions, the commencement of principal repayments will be deferred by an additional six months to March 1, 2024. Interest accrues at a variable annual rate equal to the greater of (i) 8.5% and (ii) the rate of interest noted in The Wall Street Journal, Money Rates section, as the “Prime Rate” plus 5.25%, in each case, subject to a step-down of 25 basis points upon the funding of the second tranche              
Debt issuance cost $ 119,000              
Event of Default - Loan Agreement [Member] | K2 HealthVentures LLC [Member]                
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                
Annual interest rate       5.00%   5.00%    
Debt maturity date           Aug. 01, 2024